3rd Congress of the European Group – International Society for Apheresis (E-ISFA)
Dresden, March 19 to 21, 2020
Congress Topics
- Recent progress in lipoprotein apheresis
- Homozygous familial hypercholesterolemia
- Lipoprotein(a)
- Competition with drugs
- Plasma exchange
- Immunoadsorption – indications, results, future perspectives
- Experience with extracorporeal therapy in children and during pregnancy
- Apheresis Registries
- How to assure the quality of care in extracorporeal therapy
- Psychosocial aspects in patients undergoing extracorporeal therapy
- Apheresis in transplantation
- New developments
- Specific elimination of C-reactive Protein
- After myocardial infarction, after other diseases
- Other new devices
- Specific elimination of C-reactive Protein
- Extracorporeal Photopheresis
- Cellular Therapies
- Actual aspects of lipid-lowering therapy
- New data on PCSK9 inhibitors
- Antisense oligonucleotides against apolipoprotein CIII and apolipoprotein(a)
- Bempedoic acid – current status
- New preparations of omega-3 fatty acids
- Lomitapide
- Latest study data
Further activities
- Sessions for medical staff (mostly in German)
- Role of the medical staff in an Apheresis center
- Psychological aspects
- Venous access problems
- Problems when treating children
- Different apheresis methods – advantages, disadvantages
- Other developments
- Special sessions organized by the industry (experience with apheresis devices, actual recommendations, troubleshooting)
- Actual topics in lipidology (in German, on Friday, March 20, 2018 in the afternoon, free entrance to all people wishing to attend)
Further information will follow in spring 2019